1Torrens JI,Henry BB,Serum thyrogtobulin measurement:Utility in clinical practice[J].The Endocrinologist,1996,6:125-144.
2Spencer CA,Takenuchi M,and Kazarosyan M.Current status and performance goals for serum thyroglobulin assays[J].Clin Chem,1996,42:164-173.
3Spencer CA and Wang CC.Thyrogloblin measurement:techniques,clinical benefits and pitfalls[J].Endocrinol Metab Clin North Am,1995,24:841-863.
4Van Herle A J.Serum thyroglobulin measurement in the diagnosis and management of thyroid disease[J].Thyroid March/April,1981,4:1-5.
5Solomon BL,Wartofsky L,and Burman KD.Current trends in the management of well differentiated papillary thyroid carcinoma[J].J Clin Endocrinol Metab,1996,81:333-339.
6Ladenson PW,Braverman LE,Mazzaferri EL,et al.Comparison of administration of recombinant human thyrotropin with withdraw of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma[J].N Engl J Med,1997,337:888-896.
4Bringmann I M,van Leeuwen B L,Hennemann C,et al.Outcome of treatment of hypert hyroidism[J].J Endocrinol Invest,1999,22(4):250-256.
5Whitley R J,Ain K B.Thyroglobulin:a specific serum marker for the management of thyroid carcinoma[J].Clin Lab Med,2004,24(1):29-47.
6Wallaschofaki H,Muller D,Georgi P,et al.Induction of TSH-receptor antibodies in patients with toxic multinodulargoitre by radioiodine treatment[J].Horm Metab Res,2002,34(1):36-39.
7M uratet J P,Daver A,M inier J F,et al.Influence of Scanning Doses of Iodine-131 on Subsequent First Ablative Treatment Outcome in Patients Operated on fo r D ifferent iated Thyroid Carcinoma[J].J Nucl Med,1998,39(9):1546-1550.
8Bogdan C,Frederic L,Mathalie V,et al.Optimized radioiodine therapy of Graves' disease:analysis of the delivered dose and of other possible factors affecting outcome[J].Eur J Endocrinol,1999,141(4):117-121.
